stavudine has been researched along with Insulin Resistance in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barth, RE; Chersich, MF; Grobbee, DE; Kambugu, A; Klipstein-Grobusch, K; Kumarasamy, N; Lalla-Edward, ST; Moorhouse, MA; Venter, WD; Vos, AG; Zuithoff, P | 1 |
| Arnett, DK; Bagchi, S; Chi, BH; Heimburger, DC; Kabagambe, EK; Kiage, JN; Koethe, JR; Nyirenda, CK; Wellons, MF | 1 |
| Barreiro, P; Blanco, F; González-Lahoz, J; Labarga, P; Martín-Carbonero, L; Medrano, J; Ryan, P; Soriano, V; Tuma, P; Vispo, E | 1 |
| Bani-Sadr, F; Carrieri, P; Dabis, F; Lacombe, K; Loko, MA; Morlat, P; Neau, D; Salmon, D; Serfaty, L; Winnock, M | 1 |
| Brown, TT; Dobs, AS; Kingsley, LA; Monroe, AK; Palella, FJ; Witt, MD; Xu, X | 1 |
| Dehayem, MY; Echouffo-Tcheugui, JB; Ekali, LG; Fezeu, L; Hayes, L; Johnstone, LK; Kouanfack, C; Nouthe, B; Sobngwi, E; Unwin, NC | 1 |
| Abrams, EJ; Arpadi, S; Coovadia, A; Kuhn, L; Martens, L; Patel, F; Shiau, S; Strehlau, R | 1 |
| Borgonha, S; Grinspoon, S; Hadigan, C; Rabe, J; Young, V | 1 |
| Huff, B | 1 |
| Baldwin, C; Gazzard, BG; Langroudi, B; Mandalia, S; Moyle, GJ | 1 |
| Bruunsgaard, H; Gerstoft, J; Keller, P; Lindegaard, B; Pedersen, BK | 1 |
| Buchanan, TA; Considine, RV; Deeg, MA; Degawa-Yamauchi, M; Dubé, MP; Edmondson-Melançon, H; Hernandez, J; Sattler, FR; Shankar, S; Young, EM | 1 |
| Bartsch, G; El-Sadr, WM; Gibert, C; Grunfeld, C; Kotler, D; Peng, G; Raghavan, S; Shlay, JC; Visnegarwala, F; Wang, J | 1 |
| Côté, HC; Farrar, CT; Fitch, K; Fleischman, A; Frontera, W; Grinspoon, SK; Hrovat, M; Johnsen, S; Systrom, DM; Thomas, BJ; Torriani, M | 1 |
6 trial(s) available for stavudine and Insulin Resistance
| Article | Year |
|---|---|
Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood Glucose; Cardiovascular Diseases; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; India; Insulin Resistance; Lipids; Male; Risk Factors; South Africa; Stavudine; Tenofovir; Uganda | 2018 |
Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy.
Topics: Anti-HIV Agents; Body Composition; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, Combination; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Infant; Insulin Resistance; Lamivudine; Lipids; Lopinavir; Male; Nevirapine; Ritonavir; South Africa; Stavudine | 2013 |
A 48-week, randomized, open-label comparison of three abacavir-based substitution approaches in the management of dyslipidemia and peripheral lipoatrophy.
Topics: Adult; Body Composition; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperlipidemias; Insulin Resistance; Male; Reverse Transcriptase Inhibitors; Stavudine; Time Factors | 2003 |
Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy.
Topics: Adult; Biomarkers; Blood Glucose; Carbamates; Drug Therapy, Combination; Female; Fibrinolysis; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Inflammation; Insulin Resistance; Male; Plasminogen Activator Inhibitor 1; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Sulfonamides; Tissue Plasminogen Activator | 2004 |
Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine.
Topics: Adult; Anti-HIV Agents; Body Composition; Didanosine; Dideoxynucleosides; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin; Insulin Resistance; Lamivudine; Lipids; Male; Middle Aged; Prospective Studies; Stavudine | 2005 |
Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults.
Topics: Adult; Body Composition; DNA, Mitochondrial; Female; Glucose; Glucose Clamp Technique; Humans; Insulin Resistance; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; Phosphocreatine; Phosphorus; Protons; Reverse Transcriptase Inhibitors; Stavudine | 2007 |
8 other study(ies) available for stavudine and Insulin Resistance
| Article | Year |
|---|---|
Cardiometabolic risk factors among HIV patients on antiretroviral therapy.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cyclopropanes; Female; HIV; HIV Infections; Humans; Insulin Resistance; Lamivudine; Male; Middle Aged; Nevirapine; Organophosphonates; Risk Factors; Stavudine; Tenofovir; Triglycerides; Zambia; Zidovudine | 2013 |
Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Cross-Sectional Studies; Didanosine; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Insulin Resistance; Liver Cirrhosis; Male; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine | 2011 |
Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzoxazines; CD4 Lymphocyte Count; Coinfection; Cyclopropanes; Didanosine; Female; Hepatitis C; HIV Infections; Humans; Insulin Resistance; Lipodystrophy; Liver Cirrhosis; Male; Middle Aged; Mitochondria; Sex Factors; Stavudine | 2011 |
Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection.
Topics: Adult; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus; Fasting; HIV Infections; HIV Protease Inhibitors; Humans; Insulin Resistance; Logistic Models; Lopinavir; Male; Middle Aged; Odds Ratio; Reverse Transcriptase Inhibitors; Ritonavir; Sex Hormone-Binding Globulin; Stavudine; Testosterone | 2011 |
Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood Glucose; Blood Pressure; Body Fat Distribution; Cameroon; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Health Services Accessibility; HIV Infections; Humans; Insulin Resistance; Lipids; Male; Stavudine; Time Factors | 2013 |
Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy.
Topics: Adipose Tissue; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Fatty Acids, Nonesterified; Forecasting; HIV Infections; Humans; Insulin Resistance; Lipodystrophy; Lipolysis; Male; Middle Aged; Protease Inhibitors; Stavudine; Tomography, X-Ray Computed | 2002 |
The case against Zerit.
Topics: HIV Infections; Humans; Insulin Resistance; Lactic Acid; Lipodystrophy; Mitochondria; Reverse Transcriptase Inhibitors; Stavudine | 2002 |
Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients.
Topics: Adiponectin; Adipose Tissue; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Interleukin-6; Male; Middle Aged; Protease Inhibitors; Proteins; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Tumor Necrosis Factor-alpha | 2004 |